Inflammatory genes in nasal polyposis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 1, 2008, Pages 18-21

  Figueiredo, Claudia Regina ^a   Silva, Ismael Dale Cotrim Guerreiro ^a   Weckx, Luc Louis Maurice ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines and chemokines; Inflammatory genes; Inflammatory mediators; Nasal polyposis

Indexed keywords

ARACHIDONIC ACID; CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; GROWTH FACTOR; METALLOPROTEINASE;

CELL ACTIVATION; CELL MOTION; CELL SURVIVAL; CELL TRANSPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG SENSITIVITY; EOSINOPHIL; GENE EXPRESSION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; METABOLITE; NOSE MUCOSA; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VASCULARIZATION;

ASPIRIN; CHEMOKINES; CYTOKINES; EOSINOPHILS; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METALLOPROTEASES; NASAL POLYPS;

EID: 38149098631     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282f363f1     Document Type: Review

References (30)

1. Bateman ND, Shahi A, Feeley KM, Woolford TJ. Activated eosinophils in nasal polyps: a comparison of asthmatic and nonasthmatic patients. Clin Otolaryngol 2005; 30:221-225.
2. Ediger D, Sin BA, Heper A, et al. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy 2005; 35:319-326.
3. Eliashar R, Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 2005; 13:171-175.
4. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000; 110 (3 Pt 1):422-425.
5. Kowalski ML, Grzegorczyk J, Pawliczak R, et al. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 2002; 57:493-500.
6. Gosepath J, Brieger J, Mann WJ. New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis. Am J Rhinol 2005; 19:111-116.
7. Bernstein JM, Ballow M, Rich G, et al. Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in nasal polyp? Otolaryngol Head Neck Surg 2004; 130:526-535.
8. Danielsen A, Tynning T, Brokstad KA, et al. Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum. Eur Arch Otorhinolaryngol 2006; 263:282-289. The study demonstrated mixed types of Th1 and Th2 cytokines in nasal polyposis.
9. Bachert C, Gevaert P, Holtappels G, et al. Mediators in nasal polyposis. Curr Allergy Asthma Rep 2002; 2:481-487.
10. Fan GK, Wang H, Takenaka H. Eosinophil infiltration and activation in nasal polyposis. Acta Otolaryngol 2007; 127:521-526.
11. Simon D, Braathen LR, Simon HU. Antiinterleukin-5 therapy for eosinophilic diseases. Hautarzt 2007; 58:124-127.
12. Shin SH, Lee SH, Jeong HS, Kita H. The effect of nasal polyp epithelial cells on eosinophil activation. Laryngoscope 2003; 113:1374-1377.
13. Meyer JE, Bartels J, Görögh T, et al. The role of RANTES in nasal polyposis. Am J Rhinol 2005; 19:15-20.
14. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006; 20:138-144.
15. Shin SH, Park JY, Jeon CH, et al. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope 2000; 110:1353-1357.
16. Olze H, Forster U, Zuberbier T, et al. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. Rhinology 2006; 44:145-150.
17. Woodworth BA, Joseph K, Kaplan AP, Schlosser RJ. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg 2004; 131:585-589.
18. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-1289.
19. Bradley DT, Kountakis SE. Role of interleukins and transforming growth factor-beta in chronic rhinosinusitis and nasal polyposis. Laryngoscope 2005; 115:684-686.
20. Watelet JB, Gevaert P, Bachert C, et al. Secretion of TGF-beta1, TGF-beta2, EGF and PDGF into nasal fluid after sinus surgery. Eur Arch Otorhinolaryngol 2002; 259:234-238.
21. Watelet JB, Claeys C, Perez-Novo C, et al. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004; 18:267-272.
22. Figueiredo CR, Santos RP, Silva ICG, Weckx LLM. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol 2007; 21:231-235. The authors linked the higher expression of TGFβ-1 with inhibition of nasal polyp formation.
23. Hirschberg A, Jokuti A, Darvas Z, et al. The pathogenesis of nasal polyposis by immunoglobulin-E and interleukin-5 is completed by transforming growth factor b-1. Laryngoscope 2003; 13:120-124.
24. Lechapat-Zalcman E, Coste A, D'Ortho MP, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 2001; 193:233-241.
25. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004; 59:54-60.
26. Fritz SB, Terrell JE, Conner ER, et al. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol 2003; 112:1057-1063.
27. Benson M, Carlsson L, Adner M, et al. Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps. J Allergy Clin Immunol 2004; 113:1137-1143.
28. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol 2006; 115:450-456.
29. Liu Z, Kim J, Sypek J, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy clin Immunol 2004; 114:783-790.
30. Lee JY, Lee SH, Lee HM, et al. Analysis of gene expression profiles of normal human nasal mucosa and polyp tissues by SAGE. J Allergy Clin Immunol 2006; 118:134-142. This was the first study using serial analysis of gene expression (SAGE) for determining the transcriptome in patients with nasal polyposis. The major contribution is an identification of a disease marker that may help in the management of this disease in future.